Blog

Why the FDA's AI Action Plan Falls Dangerously Short

December 4, 2025 · Policy Review @ Berkeley

The FDA's AI/ML Action Plan for regulating AI in healthcare is well-intentioned but toothless. It's voluntary, unenforceable, and leaves critical issues like algorithmic bias unaddressed. To truly protect patients, we need mandatory audits, real enforcement, and accountability.
Read full article →